Biotech launched during Covid — for Covid — looks for strategic ... Endpoints News
FDA cites 'deficiencies' in Ascendis' application for parathyroid drug ... Endpoints News
AstraZeneca inks deal with Japanese biotech JCR in CNS indication Endpoints News
Second time's the charm? Cyclerion CEO tries again at buying ... Endpoints News
U.S. Leveraged Finance and CLO Weekly (Fitch Releases 2023 ... Fitch Ratings
FTC orders Illumina to divest Grail, adding pressure amid activist ... Endpoints News
From the founders: Endpoints is now part of the Financial Times family Endpoints News
Court Ruling Could Curtail Koch’s Legal Sleight of Hand on ... Exposed by CMD
Talc lawsuits can proceed after court rejects J&J's stay bid FiercePharma
BioNTech delves into ADCs with $170M upfront weeks after Pfizer ... Endpoints News
